A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation

Hepatitis B virus (HBV) reactivation reportedly occurs frequently after hematopoietic stem cell transplantation (HSCT) in resolved HBV-infected patients. Here, 50 patients with resolved HBV infections and scheduled to undergo HSCT were enrolled; all subjects were vaccinated with three doses of hepat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Bone Marrow Transplant
Glavni autori: Nishikawa, Koji, Kimura, Kiminori, Kanda, Yoshinobu, Sugiyama, Masaya, Kakihana, Kazuhiko, Doki, Noriko, Ohashi, Kazuteru, Bae, Sung Kwan, Takahashi, Kazuhiro, Ishihara, Yuko, Mizuno, Ishikazu, Onishi, Yasushi, Onozawa, Masahiro, Onizuka, Makoto, Yamamoto, Masahide, Ishikawa, Tetsuya, Inoue, Kazuaki, Kusumoto, Shigeru, Hashino, Satoshi, Saito, Hidetsugu, Kanto, Tatsuya, Sakamaki, Hisashi, Mizokami, Masashi
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329632/
https://ncbi.nlm.nih.gov/pubmed/32071416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-0833-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items